Anti-PSCA-A11-antibody-I-124 - ImaginAb

Drug Profile

Anti-PSCA-A11-antibody-I-124 - ImaginAb

Alternative Names: 124-I-anti-PSCA-A11-minibody - ImaginAb; 124I-A11-PSCA-minibody - ImaginAb; Anti-prostate-stem-cell-antigen-A11-antibody-I-124 - ImaginAb; Anti-PSCA-A11-minibody-I-124 - ImaginAb

Latest Information Update: 19 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of California at Los Angeles
  • Developer ImaginAb Inc; University of California at Los Angeles
  • Class Antibody diagnostics; Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Bladder cancer; Pancreatic cancer; Prostate cancer

Most Recent Events

  • 26 May 2016 ImaginAb suspends a phase I trial in Bladder cancer (Diagnosis), Pancreatic cancer (Diagnosis) and Prostate cancer (Diagnosis) in USA due to temporary unavailability of anti-PSCA-A11-antibody-I-124(NCT02092948)
  • 14 Jan 2016 Anti-PSCA-A11-antibody-I-124 is still in phase I trials for Prostate cancer, Pancreatic cancer and Bladder cancer (Diagnosis) in USA
  • 01 Aug 2013 Phase-I clinical trials in Prostate cancer, Pancreatic cancer and Bladder cancer (diagnosis) in USA (IV) (NCT02092948)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top